NCT07663669 Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection
| NCT ID | NCT07663669 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Besancon |
| Condition | Antibody-mediated Rejection in Kidney Transplant |
| Study Type | OBSERVATIONAL |
| Enrollment | 31 participants |
| Start Date | 2026-06 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 31 participants in total. It began in 2026-06 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to describe, over a one-year period, the clinical, biological, and histological evolution of a cohort of kidney transplant recipients who developed antibody-mediated rejection and were treated with extracorporeal photopheresis.
Eligibility Criteria
Inclusion Criteria: * Kidney transplant recipients followed at the University Hospitals of Besançon and Lille between September 1, 2016, and August 31, 2023 * Patients with antibody-mediated rejection (as confirmed by histological analysis of the renal biopsy) * Rejection treated with extracorporeal photopheresis * Subjects who do not object to the use of their personal data and/or biological samples * Subjects affiliated with, or beneficiaries of, the French social security system Exclusion Criteria: * Patients with acute rejection * Pregnant women, women in labor, or breastfeeding mothers * Individuals deprived of liberty by judicial or administrative decision; individuals receiving compulsory psychiatric care; or individuals admitted to a healthcare or social institution for reasons other than research participation * Minors * Adults under legal protection or unable to provide informed consent * Subjects without health insurance coverage * Subjects currently within an exclusion period from another study, or as listed in the "national volunteer registry"
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07663669 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Antibody-mediated Rejection in Kidney Transplant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07663669 currently recruiting?
Yes, NCT07663669 is actively recruiting participants. Contact the research team at cvauchy@chu-besancon.fr for enrollment information.
Where is the NCT07663669 trial being conducted?
This trial is being conducted at Besançon, France.
Who is sponsoring the NCT07663669 clinical trial?
NCT07663669 is sponsored by Centre Hospitalier Universitaire de Besancon. The trial plans to enroll 31 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.